Importantly, tumor tissues from A549-engrafted mice treated with AdV-Cas9-sgG12S and dCas9-KRAB-sgG12S both showed significant reduction of KRAS G12S protein through in situ IHC staining, but this same reduction was not observed in the control groups (Figure 5C, 5D). Here, KRAS is linked to neoplasm.